GL1X · GenesisL1 explorer

MolNFT v1 · #89525 · protein

Three dimensional structure of de novo designed serine hydrolase OSH26, northeast structural genomics consortium (nesg) target OR89

4DRT · De novo designed serine hydrolase, OR89: “Three dimensional structure of de novo designed serine hydrolase OSH26, northeast structural genomics…”. X-ray diffraction, 2 ligands (NA, CL), 2 pockets (best druggability 0.46). MolNFT v1…

PDB
4DRT
Type
protein
Length
352 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
De novo designed serine hydrolase, OR89
Ligands
NA, CL
Pockets
2 · best druggability 0.46

Structure

x-ray diffraction · 1 distinct chain · 27% helix, 33% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
ADe novo designed serine hydrolase, OR89protein35227% helix, 33% strand—

Ligands and binding sites

  • NA · Sodium ion · metal · chains A
  • CL · Chloride ion · ion · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

2 pockets found on a 1 Å grid, 0 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
1990.460.8019empty
21050.380.7420empty

Modifications

Observed in the structure: 13 modified (engineered).

Compared structures

  • 4DRT · Three dimensional structure of de novo designed serine hydrolase OSH26, Northeast… · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.